(Q53369015)

13 May 2018

title

CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. (English)

1 reference

13 May 2018

0 references

6

Paul R Sanberg

1 reference

13 May 2018

Richard Flavell

9

object named as

Richard A Flavell

1 reference

13 May 2018

author name string

Kirk P Townsend

1

1 reference

13 May 2018

Terrence Town

2

1 reference

13 May 2018

Takashi Mori

3

1 reference

13 May 2018

Lih-Fen Lue

4

1 reference

13 May 2018

Doug Shytle

5

1 reference

13 May 2018

David Morgan

7

1 reference

13 May 2018

Francisco Fernandez

8

1 reference

13 May 2018

Jun Tan

10

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 March 2005

1 reference

13 May 2018

European Journal of Immunology

published in

1 reference

13 May 2018

volume

35

1 reference

13 May 2018

page(s)

901-910

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Microglia: a sensor for pathological events in the CNS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Amyloid β protein deposition and neuron loss in osteopetrotic (op/op) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200425585

1 reference

7 January 2021

Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

MHC class II and CD40 play opposing roles in dendritic cell survival.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Complement component C1q modulates the phagocytosis of Abeta by microglia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200425585

1 reference

7 January 2021

Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

MHC class II-positive microglia in human brain: association with Alzheimer lesions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Modulation of MHC class II expression in the absence of lymphocytic infiltrates in Alzheimer's retinae.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Developmental plasticity of CNS microglia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Regulating factors for microglial activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Accelerated phagocytosis of amyloid-beta by mouse and human microglia overexpressing the macrophage colony-stimulating factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425585

7 January 2021

Identifiers

DOI

10.1002/EJI.200425585

1 reference

13 May 2018

PubMed ID

15688347

1 reference

13 May 2018